Anixa Biosciences Inc. (ANIX)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
3 |
$182,130 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
10 Apr 2024 |
TITTERTON LEWIS H JR |
Director |
09 Apr 2024 |
15,009 |
3.28 |
49,230 |
15 Mar 2024 |
BASKIES ARNOLD M |
Director |
15 Mar 2024 |
10,000 |
3.63 |
36,300 |
15 Mar 2024 |
KUMAR AMIT |
Chief Executive Officer |
15 Mar 2024 |
30,000 |
3.22 |
96,600 |
21 Jul 2023 |
CATELANI MICHAEL |
President, COO & CFO |
20 Jul 2023 |
5,500 |
3.64 |
20,020 |
27 Apr 2022 |
TITTERTON LEWIS H JR |
Director |
26 Apr 2022 |
10,000 |
2.79 |
27,900 |
22 Apr 2022 |
CATELANI MICHAEL |
President |
21 Apr 2022 |
5,500 |
2.66 |
14,630 |
21 Apr 2022 |
CATELANI MICHAEL |
President |
20 Apr 2022 |
2,509 |
2.53 |
6,348 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock